Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
CureVac NV
5CVCurrent price
2.65 EUR
0 EUR (0.00%)
Last closed
2.75 USD
Company
www.curevac.com
ISIN
NL0015436031
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
637 051 712 USD
Yield for 12 month
-51.72 %
1Y
3Y
5Y
10Y
15Y
5CV
CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany. Address: Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.92 USDP/E ratio
–Dividend Yield
–Current Year
+56 120 681 USD
Last Year
+71 856 032 USD
Current Quarter
+15 463 664 USD
Last Quarter
+13 187 106 USD
Current Year
-97 072 766 USD
Last Year
-124 243 151 USD
Current Quarter
-33 278 587 USD
Last Quarter
-31 244 904 USD
Key Figures 5CV
1 year
3 years
5 years
10 years
EBITDA
-270 342 016 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.52 %
PEG Ratio
–
Return On Equity TTM
-54.3 %
Wall Street Target Price
7.92 USD
Revenue TTM
65 859 000 USD
Book Value
1.68 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
90.5 %
Dividend Yield
–
Gross Profit TTM
-91 549 000 USD
Earnings per share
-1.34 USD
Diluted Eps TTM
-1.34 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 5CV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 5CV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 5CV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
5.2356
Enterprise Value Revenue
6.3905
Price Sales TTM
9.673
Enterprise Value EBITDA
-0.6624
Price Book MRQ
1.571
Financials 5CV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 5CV
For 52 weeks
2.22 USD
6.3 USD
50 Day MA
2.95 USD
Shares Short Prior Month
4 785 625
200 Day MA
3.24 USD
Short Ratio
11.67
Shares Short
4 708 812
Short Percent
11.75 %
BeatStart